SHANGHAI, May 8, 2018 /PRNewswire/ — WuXi AppTec Co., Ltd. (“WuXi AppTec” or “the Company”; Stock Code: 603259), a leading global pharmaceutical and medical device Continue Reading
WuXi STA Changzhou Site Passes First U.S. FDA Inspection
The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval SHANGHAI, May 7, 2018 /PRNewswire/ — STA Pharmaceutical Continue Reading
Vieworks’ VIVIX-S N Series Receives CFDA Clearance
-By strengthening the wireless X-ray flat panel detector lineup, Vieworks is expecting to revamp sales in China ANYANG, South Korea and BEIJING, May 7, 2018 Continue Reading
Mundipharma licenses Starpharma’s VivaGel BV
– Mundipharma licenses Starpharma’s VivaGel® BV for Asia, Middle East, Africa and the majority of Latin America, to be marketed as part of the popular Continue Reading
CStone announces first patient dosed with anti-CTLA-4 antibody CS1002 of a Phase I study in Australia
SUZHOU, China, May 4, 2018 /PRNewswire/ — CStone Pharmaceuticals (Suzhou) Co., Ltd., (CStone) today announced dosing of the first patient of a Phase I clinical Continue Reading
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
Conference call to take place Friday, May 11, 2018 at 8:30 am Eastern time ISNES, Belgium, May 4, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) Continue Reading
China Biologic Reports Financial Results for the First Quarter of 2018
–1Q18 Total Sales Up 13.7% YoY and Non-GAAP Adjusted Net Income Up 2.1% YoY in RMB terms, or Total Sales Up 23.0% YoY to $112.5 Continue Reading
10 Years of Digital Chest Drainage: Medela’s Milestones Show How State-Of-The-Art Technology Has Transformed Today’s Post-Operative Patient Care
BAAR, Switzerland , May 3, 2018 /PRNewswire/ — From Heber-principle to digital systems, thoracic surgery has significantly changed and improved over the course of time Continue Reading
AGC Biologics Enters into Commercial Manufacturing Agreement with Horizon Pharma plc
Manufacture of teprotumumab for treatment of thyroid eye disease COPENHAGEN, Denmark, May 3, 2018 /PRNewswire/ — AGC Biologics, a global leader in clinical and commercial manufacturing Continue Reading
Beckman Coulter Achieves CE Mark for Its Early Sepsis Indicator*
First-of-its-kind hematology-based test intended to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis as part of a routine CBC Continue Reading